• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

kens august stock purchase

Anonymous

Guest
the rich keep gettin richer---bought at 31.77 and at moment it is at 35.18--lets see, 32,000 shares adds up to about a cool million smackers for our leader--it would be nice if we all could see the books
 
















the rich keep gettin richer---bought at 31.77 and at moment it is at 35.18--lets see, 32,000 shares adds up to about a cool million smackers for our leader--it would be nice if we all could see the books

Damn, Ken said he would cal lif he had an insider info. Nice timing on the purchase though don't you think?
 




Lets not forget this may also be part of his contract as CEO. If it reaches a certain selling price he gets a certain amount of stock options. Either way "the rich just get richer"